NUTX Nutex Health, Inc.

Nasdaq nutexhealth.com


$ 95.00 $ -1.87 (-1.93 %)    

Friday, 17-Oct-2025 19:37:07 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 94.835
$ 96.10
$ 93.89 x 6
$ 97.47 x 50
$ 92.95 - $ 97.81
$ 21.45 - $ 184.28
85,040
na
527.82M
$ 1.26
$ 7.86
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2025 03-31-2025 10-Q
2 03-31-2025 12-31-2024 10-K
3 11-07-2024 09-30-2024 10-Q
4 08-08-2024 06-30-2024 10-Q
5 05-08-2024 03-31-2024 10-Q
6 03-28-2024 12-31-2023 10-K
7 11-09-2023 09-30-2023 10-Q
8 08-09-2023 06-30-2023 10-Q
9 05-15-2023 03-31-2023 10-Q
10 03-03-2023 12-31-2022 10-K
11 11-21-2022 09-30-2022 10-Q
12 08-22-2022 06-30-2022 10-Q
13 05-13-2022 03-31-2022 10-Q
14 03-31-2022 12-31-2021 10-K
15 11-15-2021 09-30-2021 10-Q
16 08-16-2021 06-30-2021 10-Q
17 05-24-2021 03-31-2021 10-Q
18 04-05-2021 12-31-2020 10-K
19 11-16-2020 09-30-2020 10-Q
20 08-19-2020 06-30-2020 10-Q
21 06-29-2020 03-31-2020 10-Q
22 05-14-2020 12-31-2019 10-K
23 11-19-2019 09-30-2019 10-Q
24 08-20-2019 06-30-2019 10-Q
25 05-20-2019 03-31-2019 10-Q
26 04-16-2019 12-31-2018 10-K
27 11-20-2018 09-30-2018 10-Q
28 08-14-2018 06-30-2018 10-Q
29 05-15-2018 03-31-2018 10-Q
30 04-17-2018 12-31-2017 10-K
31 11-20-2017 09-30-2017 10-Q
32 08-18-2017 06-30-2017 10-Q
33 05-22-2017 03-31-2017 10-Q
34 04-17-2017 12-31-2016 10-K
35 11-21-2016 09-30-2016 10-Q
36 08-22-2016 06-30-2016 10-Q
37 05-23-2016 03-31-2016 10-Q
38 04-14-2016 12-31-2015 10-K
39 11-16-2015 09-30-2015 10-Q
40 08-18-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 derivative-lawsuit-filed-against-nutex-health-executives-and-board-alleging-mismanagement-fiduciary-breaches-and-securities-violations

On September 8, 2025, a purported stockholder filed a derivative action (the "Derivative Action") on behalf of Nutex He...

 maxim-group-maintains-buy-on-nutex-health-lowers-price-target-to-205

Maxim Group analyst Anthony Vendetti maintains Nutex Health (NASDAQ:NUTX) with a Buy and lowers the price target from $225 t...

 nutex-health-faces-securities-class-action-lawsuit-filed-august-22-2025-alleging-violations-tied-to-short-seller-report

On August 22, 2025, a putative securities class action complaint was filed in the United States District Court for the Southern...

 reported-earlier-nutex-health-preliminary-q2-revenue-244m-up-from-761m-yoy-adjusted-ebitda-716m-up-from-68m-yoy

Financial highlights for the three months ended June 30, 2025:Total revenue was $244.0 million for the three months ended June ...

 reported-earlier-nutex-health-to-delay-filing-its-form-10-q-for-the-period-ending-june-30-2025-provides-preliminary-financial-results-for-the-three-and-six-months-ended-june-30-2025-total-revenue-was-2440m-for-the-three-months-ended-june-30-2025

HOUSTON, Aug. 14, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a phy...

 nutex-health-inc-announces-25m-stock-repurchase-program

-SEC Filing

 nutex-health-responds-to-short-seller-allegations-says-strongly-disagrees-with-the-allegations-in-the-report-and-believes-it-is-without-merit-believes-the-report-contains-misrepresentations-and-conveys-a-misunderstanding-of-nutex-healths-business

Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare deliv...

 short-seller-raises-questions-over-micro-hospital-operator-nutex-healths-arbitration-windfall

Nutex Health's stock surge draws scrutiny amid lawsuits targeting its arbitration vendor, raising questions about inflated ...

 watching-nutex-health-blue-orca-capital-issues-report-on-co-stating-it-is-short

https://www.blueorcacapital.com/blue-orca-is-short-nutex-health-inc/

 benchmark-maintains-buy-on-nutex-health-raises-price-target-to-300

Benchmark analyst Bill Sutherland maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $150 to $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION